In Caenorhabditis elegans, an X chromosome-counting mechanism specifies sexual fate. Specific genes termed X-signal elements, which are present on the X chromosome, act in a concerted dose-dependent fashion to regulate levels of the developmental switch gene xol-1. In turn, xol-1 levels determine sexual fate and the activation state of the dosage compensation mechanism. The crystal structure of the XOL-1 protein at 1.55 Å resolution unexpectedly reveals that xol-1 encodes a GHMP kinase family member, despite sequence identity of 10% or less. Because GHMP kinases, thus far, have only been characterized as small molecule kinases involved in metabolic pathways, for example, amino acid and cholesterol synthesis, XOL-1 is the first member that controls nonmetabolic processes. Biochemical investigations demonstrated that XOL-1 does not bind ATP under standard conditions, suggesting that XOL-1 acts by a mechanism distinct from that of other GHMP kinases. In addition, we have cloned a XOL-1 ortholog from Caenorhabditis briggsae, a related nematode that diverged from C. elegans ∼50-100 million years ago. These findings demonstrate an unanticipated role for GHMP kinase family members as mediators of sexual differentiation and dosage compensation and, possibly, other aspects of differentiation and development.
Sex determination is the critical and universal developmental pathway underlying sexual reproduction. Its manifestations are pervasive and often conspicuous. Whereas the presence or absence of the Y chromosome dictates male or female development in mammals, sexual fate in the fruit fly Drosophila melanogaster and the free-living nematode Caenorhabditis elegans is determined genetically by the number of X chromosomes relative to the number of sets of autosomes. In mammals, the primary sex determining gene is SRY, which is present only on the Y chromosome and encodes an HMG domain-containing transcription factor. In the fruit fly, the primary sex determination gene Sex-lethal (Sxl; Maine et al. 1985 ) is a female-specific trans-acting gene regulator that binds tra transcripts and directs alternative splicing (Inoue et al. 1990 ). The SRY (Werner et al. 1995) and SXL (Handa et al. 1999) interactions with polynucleotides have been characterized structurally. In C. elegans, sexual differentiation is regulated by the expression levels of the developmental switch gene xol-1. High and low levels of xol-1 result in male (XO) and hermaphrodite (XX) development (Fig. 1) , respectively. XOL-1 activity is absolutely required for proper sexual differentiation and male viability (Rhind et al. 1995) , but its mechanism of action is unknown.
The cooperative activity of at least four X-linked genes, termed X-signal elements, represses expression of xol-1 (for review, see Meyer 2000a) . By doubling the number of X-signal elements, an XX embryo reduces xol-1 expression by ∼10-fold (Rhind et al. 1995) , facilitating hermaphrodite development. Two C. elegans X-signal elements have been characterized molecularly as follows: FOX-1 (Hodgkin et al. 1994; Nicoll et al. 1997; Skipper et al. 1999) , an RNA-binding protein that may regulate alternate splicing of xol-1 RNA, and SEX-1 (Carmi et al. 1998 ), a nuclear receptor and likely a tran-scription factor. Although hermaphrodites and males differ in X chromosome number, the expression of most X-linked genes must be equal to ensure viability. This is accomplished through dosage compensation, which reduces expression of X-linked genes in hermaphrodites to male levels (for reviews, see Wood et al. 1997; Hansen and Pilgrim 1999; Meyer 2000b; Boag et al. 2001) . High levels of XOL-1 in males correlate with low SDC-2 expression, preventing dosage compensation (Miller et al. 1988; Rhind et al. 1995) . Conversely, low levels of XOL-1 in hermaphrodites correlate with high SDC-2 expression and the assembly on the X chromosome of the dosage compensation complex, which is composed of sdc, dpy, and mix-1 gene products (Nonet and Meyer 1991; Chuang et al. 1996; Lieb et al. 1996 Lieb et al. , 1998 Davis and Meyer 1997; Dawes et al. 1999; Chu et al. 2002) . Other genes downstream of xol-1, such as her, tra, and fem, whose activities are inversely related in hermaphrodites and males, coordinate sexual differentiation (Goodwin and Ellis 2002) . Null mutants of xol-1 are XO-lethal, inappropriately activating dosage compensation where only one X chromosome is present, whereas XOL-1 overexpression is XX-lethal, deactivating the dosage compensation pathway and elevating the expression of X chromosome genes to lethal levels in hermaphrodites (Rhind et al. 1995) .
XOL-1 is an acidic 51-kD nuclear protein (pKa 4.6), whose transcript is expressed at high levels only in precomma stage XO embryos (Rhind et al. 1995) . XOL-1 transcripts are present in low levels throughout other larval stages in XO animals, but are nearly undetectable in XX larvae and adults of both sexes (Rhind et al. 1995) .
Currently, XOL-1 is annotated as a subtilisin-like protease on the basis of primary sequence (http://www.wormbase.org). BLAST searches of Genbank failed to identify any homologs that may have provided additional clues as to the function of XOL-1. Thus, we used x-ray crystallography to investigate the function of XOL-1, hypothesizing that the three-dimensional structure of the protein would yield insights into its nature, largely uncharacterized biochemically. The resulting crystal structure of XOL-1 ( Fig. 2A ) unambiguously and unexpectedly defines XOL-1 as a member of the GHMP kinase family, a family of proteins known to be involved in small molecule metabolism, but not known to participate directly in sexual differentiation or dosage compensation.
Galactokinase, homoserine kinase, mevalonate kinase, and phosphomevalonate kinase were originally identified as prototypic members of the GHMP kinase family and observed to contain a conserved Pro-Xaa 3 -Gly-Leu-Gly-Ser-Ser-Ala-Ala motif (Fig, 3A) that was hypothesized (Tsay and Robinson 1991; Bork et al. 1993) , and later proved (Zhou et al. 2000; Krishna et al. 2001; Fu et al. 2002) to be involved in ATP binding. The nucleotide fold of GHMP kinases is distinct from those of other kinases, that is, P-loop, protein, and Hsp70-like kinases (Zhou et al. 2000; Bonanno et al. 2001; Fu et al. 2002; Romanowski et al. 2002; Yang et al. 2002) , and binds ATP in both syn and anti-conformations (Zhou et al. 2000; Fu et al. 2002) . GHMP kinases are found in bacteria, archaea, and eukaryotes and contain an unusual lefthanded ␤-␣-␤ fold similar to that observed in domain IV of elongation factor G (Zhou et al. 2000) . In humans, deficiency of galactokinase, which participates in the Genetic control of sex determination and dosage compensation in C. elegans. xol-1 is the primary sex-determination switch gene and the direct molecular target of the X-chromosome counting mechanism. (Top) Male (XO). High xol-1 activity specifies male fate by repressing the activity of sdc-1, sdc-2, and sdc-3 genes. Overt male sexual characteristics include a one-armed gonad (yellow) and a highly specialized tail used for mating. The dosage compensation machinery (colored ovals) does not bind to the X chromosome. Thus, X chromosome gene expression is unregulated (red chromosome). DC, dosage compensation complex (i.e., DPY-26, DPY-27, DPY-28, and MIX-1). (Bottom) Hermaphrodite (XX). Low xol-1 activity specifies hermaphrodite fate by allowing the activation of sdc-1, sdc-2, and sdc-3 genes. Overt hermaphrodite sexual characteristics include a two-armed gonad (yellow, with brown oocytes and embryos) and a tapered tail. The sdc-1,sdc-2, and sds-3 gene products (colored rectangles) recruit a large complex of dosage compensation proteins (DC, colored ovals) to both X chromosomes, repressing X gene expression by half (brown chromosome).
conversion of galactose to glucose, contributes to cataract formation (Monteleone et al. 1971; Beutler 1972; Harley et al. 1972; Levy et al. 1972) . Mutations in mevalonate kinase, an enzyme involved in the synthesis of sterols from acetate, are associated with mevalonic aciduria (Hoffmann et al. 1986; Schafer et al. 1992; Houten et al. 1999b ) and hyperimmunoglobulinemia D/periodic fever syndrome (Drenth et al. 1999; Houten et al. 1999a Houten et al. , 2001 Cuisset et al. 2001; Rios et al. 2001; Simon et al. 2001) . To date, no GHMP kinases have been shown to function in developmental pathways unrelated to metabolism.
Results

XOL-1 is a GHMP kinase family member
Full-length XOL-1 (417 residues), as well as various Nand C-terminal truncation mutants, were overexpressed and purified from Escherichia coli. N-and C-terminal truncations were designed on the basis of biological data (Rhind et al. 1995) and secondary structure predictions. A C-terminal truncation mutant (residues 1-374), which retained full rescue activity of xol-1 null males (Rhind et al. 1995) , crystallized in the orthorhombic space group P2 1 2 1 2 with unit cell dimensions a = 116.1 Å, b = 86.0 Å, and c = 80.2 Å, with two molecules per asymmetric unit (V m = 2.4 Å 3 /Da). Initial phases and the positions of selenium atoms of a selenomethionine-derivatized XOL-1 (see Materials and Methods) were determined by MAD at 2.5 Å. The structure was further refined by phase extension using native data to 1.55 Å. The final R values for the refined model are R cryst = 20.1 and R free = 21.2 (Table  1 ). The final model contains two XOL-1 molecules per asymmetric unit consisting of 703 amino acid residues and 628 water molecules. Superimposition of monomer 2 (chain B) onto monomer 1 (chain A) yielded an r.m.s. deviation of 0.17 Å for all equivalent backbone atoms, A conserved acidic C-terminal motif is highlighted in green. Identically conserved residues are highlighted in red and conservatively substituted residues are in blue. Secondary structure is assigned above.
indicating no significant differences between the two molecules in the asymmetric unit. The following regions were omitted from the final model for lack of interpretable density: residues 1-7, 29-38, and 190-195 in monomer 1 and residues 1-7, 29-38, and 190-194 in monomer 2.
Submission of the XOL-1 atomic coordinates to the Dali server (Holm and Sander 1993; http (Table 2) . Despite indisputable structural similarity, XOL-1 displays remarkably little sequence similarity to other members of the family, with overall sequence identities returned from the Dali server of 9%-10%. Even within the GHMP kinase conserved motif1, motif2, and motif3 ( Fig. 3A) , the sequence is highly divergent. In fact, throughout the entire sequence, only one structurally equivalent residue (Gly 123 in motif2) is absolutely conserved [Figs. 3A (in red) , 4B] among XOL-1 and the five GHMP kinase structures deposited in the PDB. Although, across subfamilies of GHMP kinases, sequence indentity can be surprisingly low , sequence identity is sufficiently high within subfamilies to convincingly delineate related enzymes. Thus, XOL-1 is the first GHMP kinase family member to be identified solely from structural information. In addition, the role of XOL-1 in sexual differentiation was 
, where <I(h)> is the mean of the I(h) observation of reflection h.
R free was calculated as for R cryst , but on 5% of the data, excluded from the refinement. completely incongruous with known GHMP kinase functions.
The overall secondary structure of XOL-1 is mixed, containing 10 ␣-helices and 13 ␤-strands, which fold into an elongated dumbbell-shape ( Yang et al. 2002; Fig. 2B,C) , the GHMP kinase core of XOL-1, which excludes ␤-strands 1 and 13 formed by the extended N and C termini ( Fig. 2A) , consists of two domains, each composed of four associated ␣-helices, associated ␤-strands, and a single, short, isolated ␣-helical segment. Domain 1 contains a bundle of four ␣-helices (␣2, ␣3, ␣4, ␣5; Fig. 2A , in yellow), a ␤-sheet (␤12, ␤2, ␤3, ␤5, ␤4) with two associated strands (␤6, ␤7; Fig. 2A , in cyan), and a short, isolated ␣-helix (␣1; Fig.  2A , in magenta). Domain 2 contains four ␣-helices packed side-by-side (␣7, ␣8, ␣9, ␣10; Fig. 2A , in green) on one side of the ␤-sheet (␤9, ␤10, ␤8, ␤11; Fig. 2A, in red) , and a short ␣-helix (␣6; Fig. 2A, in green) , which connects the ␤-sheets from domains 1 and 2.
Identification of a XOL-1 ortholog in C. briggsae 
The putative catalytic site of XOL-1 and implications for activity
The putative active site of XOL-1 is a deep cavity nestled in the interface of domains 1 and 2 (Fig. 4) , a position analogous to that occupied by the active sites of other GHMP kinases (Fig. 2B) . The surface of the cavity is largely electronegative with interspersed electropositive regions defined by Lys 124 and Arg 264 (Fig. 4A,B) . The negatively charged residues lining the cavity are Asp 52, Asp 120, Asp 220, Glu 276, and Glu 297 (Fig. 4A,B) , only one of which (Asp 120) is apparently conserved in the C. briggsae ortholog (Asp 116; Fig. 4C,D) . The phosphatebinding loop (residues 120-129), which connects ␤5 and ␣3, straddles the back of the cavity (Fig. 4B) . Although the XOL-1 motif2 contains two tandem serines (121, 122; Fig. 3A , in boxes), as in other GHMP kinases, the positions of these residues are not analogous. Whereas in other GHMP kinases the tandem serines are incorporated into the first turn of the ensuing ␣-helix, these positions are occupied by the hydrophobic residues Ala 132 and Val 133 in XOL-1, and the tandem serines are located within the loop several residues before the start of the corresponding ␣-helix, ␣3 (Fig. 4A,B The surprising structure of XOL-1 implies that, in this case, the GHMP kinase fold acts as a developmental gene regulator or that sexual differentiation in C. elegans is regulated in a manner only remotely considered previously, that is, by a small secondary effector molecule. Thus, the structure suggests new avenues of experimentation that otherwise would likely have been overlooked.
The XOL-1 used in the structure determination (residues 1-374) lacks the highly acidic feminizing C terminus (residues 375-417), yet retains complete ability to rescue xol-1 null males (Rhind et al. 1995) . Therefore, the structure does not provide information as to the function of this short C-terminal domain, which, thus far, has not been observed in other GHMP kinases. However, it can be deduced from the structure that the GHMP kinase core of XOL-1 does not incorporate the acidic C terminus. A conserved acidic motif at the extreme C termini is apparent in the aligned C. elegans and C. briggsae XOL-1 orthologs (residues 408-413 in C. elegans XOL-1; QDDTYD, residues 416-421 in C. briggsae XOL-1; NDDTFD), the functional significance of which is unknown (Fig. 3B, highlighted in green) .
XOL-1 binding to ATP is not detectable
The characterization of XOL-1 as a member of the GHMP kinase family of proteins led us to test whether XOL-1 could bind ATP. UV cross-linking failed to detect binding of XOL-1 to isotopically labeled ATP (data not shown). Likewise, residual XOL-1-catalyzed ATP hydrolysis was not detectable in an enzyme-coupled colorimetric assay (Fig. 5A) . These results were confirmed by fluorescence spectroscopy. The fluorescent probe TNP-ATP, which had been used in studies of human mevalonate kinase , did not display any significant enhancement of fluorescence in the presence of XOL-1 (Fig. 5B) . In addition, crystals were both soaked and grown in the presence of a 10-fold molar excess of either ATP or the nonhydrolyzable analog AMP-PNP. However, no additional density was observed in the putative catalytic site in electron density maps calculated from x-ray diffraction data collected from these crystals (data not shown). Therefore, XOL-1 may not be a small molecule kinase, having evolved and adapted a GHMP kinase scaffold to execute a completely novel function. The lack of sequence similarity present between XOL-1 and other GHMP kinases, even within previously iden- tified conserved motifs (Fig. 3A) , supports this conclusion. Of note, the left-handed ␤-␣-␤ fold in the N-terminal domain of XOL-1 and other GHMP kinases, termed the ribosomal protein S5 domain 2-like fold, is found in numerous RNA/DNA-binding proteins, raising the intriguing possibility that XOL-1 may interact with polynucleotide substrates, although, for this to be the case, significant conformational change in the active site would seem to be required. Structural similarity has also been noted between an RNA-binding protein domain, for example, domain V of elongation factor G, and the Cterminal domain of homoserine kinase (Zhou et al. 2000) . Interestingly, RNA-binding domain 2 of the Sexlethal protein has a fold similar to that of elongation factor G. The possibility remains that XOL-1-ATP binding may require an additional uncharacterized interaction.
Implications of crystal packing for oligimeric structure
Although the biological oligomerization state of XOL-1 is unknown, crystal packing suggests that XOL-l might be a dimer or even a tetramer. One possible mode of dimerization evident from the crystal packing of XOL-1 involves the reciprocal interactions of domains 1 and 2 from neighboring monomers (Fig. 6A ) with a buried surface area of 2146 Å 2 per dimer, slightly less than that calculated for R. norvegicus mevalonate kinase (2450 Å 2 ; Fu et al. 2002) . The additional structural feature formed by the unique N-and C-terminal ␤-strands (␤1 and ␤13) of XOL-1 (Fig. 3A) presents a second possible interface for dimerization. XOL-1 molecules pack in the crystal such that ␤1 strands link ␤-sheets from adjacent monomers to form an extended 12-stranded antiparallel ␤-sheet comprised of 6 strands from each monomer (␤9, ␤10, ␤8, ␤11, ␤13, ␤1; Fig. 6B ). As a caveat, extended ␤-sheets that do not correlate with functional dimerization are sometimes observed in crystal structures (Schiffer et al. 1985) . In addition, XOL-1 elutes as a monomer during size exclusion chromatography (data not shown).
Crystal structures of homoserine kinase (Zhou et al. 2000) and mevalonate kinase (R. norvegicus; Fu et al. 2002 ) reveal a possible mode of dimerization mediated through interactions between C-terminal domains. However, the crystal structure of XOL-1 does not reflect a similar mode of dimerization, as the molecules are packed in a head-to-toe array with corresponding C-terminal dimerization interfaces distal to each other, an arrangement more similar to that seen in the mevalonate decarboxylase dimer (Bonanno et al. 2001 ). The two potential modes of XOL-1 dimerization combine to form a tetrameric entity with a large central cavity having a diameter of ∼45 Å at its core (Fig. 6C) .
Discussion
The identification of XOL-1 as a GHMP kinase family member through the elucidation of its crystal structure is difficult to reconcile with its role as a developmental regulator. However, gene regulation by GHMP kinase family members has precedent in yeast. Saccharomyces cerevisiae Gal3p, whose primary structure is highly similar to that of galactokinase, is a galactose-and ATPdependent transcriptional inducer of GAL genes (Platt and Reece 1998; Platt et al. 2000) . Moreover, GAL1 of Kluyveromyces lactis is a bifunctional protein that acts as an inducer of GAL genes and a galactokinase. . As our understanding of how S. cerevisiae Gal3p and K. lactis GAL1 induce gene expression is incomplete, their relationship to XOL-1 does not enable us to predict a detailed mechanism; however, circumstantial evidence suggests a mechanism of gene regulation that is conserved across phyla.
The principles of sexual dimorphism and dosage compensation are conserved in multicellular eukaryotes, but the mechanisms are not. For instance, in female mammals, a single X chromosome is inactivated randomly to reduce the overall X-linked expression by half, thereby reducing X chromosome gene expression to male levels. In the fruit fly, the single male X chromosome is hypertranscribed, such that X chromosome gene expression is doubled to female levels. In C. elegans, transcription from both hermaphrodite X chromosomes is reduced by half. With only one XOL-1 ortholog identified, the extent to which XOL-like GHMP kinases might regulate sexual fate and dosage compensation in other eukaryotes cannot be assessed. Because dosage compensation in different eukaryotic lineages is thought to have evolved independently, regulation of sexual fate and dosage compensation by XOL-like GHMP kinases may be limited to C. elegans and related nematodes. However, XOL-like GHMP kinases may also participate considerably more extensively, not only in the regulation of sexual fate and dosage compensation, but in other modes of development and differentiation. The accelerated rate at which genes involved in sexual differentiation and dosage compensation have evolved may obscure related gene sequences. Presumably, XOL-1 is a case of rapidly divergent evolution as such a remarkable degree of structural similarity would less likely be manifested by a case of convergence. Ambiguities will likely only be resolved when both sequence and structure space are more densely populated. To this end, structural genomic (Bonanno et al. 2001; Burley and Bonanno 2002) and wholegenome sequencing projects will undoubtedly provide indispensable insights.
Nematodes, which may be free-living or parasitic, are among the most numerous animals on earth and populate terrestrial, aquatic, and marine environments in abundance. C. elegans, whose entire genome has been sequenced (The C. elegans Sequencing Consortium 1998), is the most thoroughly studied nematode species and a useful organism for the study of parasitic nematodes (Burglin et al. 1998; Favre et al. 1998; Ashton et al. 1999; Blaxter and Ivens 1999) . Efforts to characterize the genomes of parasitic nematodes (The Filarial Genome Project: http//nema.cap.ed.ac.uk/fgp.html) have already resulted in the identification of the apparent homolog of C. elegans male sex determination gene her-1 in Brugia malayi (Streit et al. 1999) . A her-1 homolog has also been XOL-1 is a GHMP kinase family member
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identified in C. briggsae (Streit et al. 1999) , and homologs of C. elegans hermahrodite sex determination gene tra-2 have been identified in C. briggsae (Kuwabara and Shah 1994) and Caenorhabditis ramanei (Haag and Kimble 2000) . These findings imply that, despite differing strategies of sexual reproduction between nematode species, some elements of the process are conserved. We infer from these observations that XOL-like GHMP kinases may play an important role in the development and differentiation of various nematodes. Furthermore, XOL-like GHMP kinases may regulate differentiation in related organisms such as other helminths, for example, schistosomes and, perhaps even more broadly, in other metazoans. It is likely that the precise mechanism of XOL-1 activity will eventually emerge from studies based on the discoveries described herein. In summary, the structure of XOL-1 demonstrates that the GHMP kinase family of proteins is much more diverse in sequence and function than had been presumed, and that critical pathways in development and differentiation may be controlled by a subfamily of enzymes preliminarily termed XOL-like GHMP kinases.
Materials and methods
Protein expression and purification
Full-length XOL-1 and a series of C-and N-terminal truncation mutants were generated by PCR and expressed with N-terminal polyhistidine tags in pRSET-A (Invitrogen) and PET28a (Novagen) vectors. Protein expression in BL21 DE3 strain E. coli was induced with 1 mM IPTG at a cell density of ∼0.6 OD at 600 nm. Induction took place overnight at room temperature or 16°C. Protein was purified by Ni + -affinity and anion exchange chromatography. N-terminal polyhistidine tags were removed by thrombin or enterokinase cleavage followed by an additional application of anion exchange chromatography. Selenomethionine-labeled protein was generated in the methionine-auxotrophic strain B834 DE3 (Novagen) in a similar manner, but bacteria were grown in methionine-deficient minimal medium supplemented with 0.3 mM L-selenomethionine (Sigma). Incorporation of selenomethionine into the recombinant protein was confirmed by MALDI mass spectrometry.
Crystallization and data collection
The C-terminal truncation mutant consisting of residues 1-374 (80 mg/mL) crystallized at 4°C from 0.1 M HEPES (pH 7.8), 0.2 M MgCl 2 , 17.5% PEG400. MPD (>5%) was used as an additive to improve crystal size and quality. Crystals were harvested from drops with nylon cryoloops (Hampton Research) and directly cryocooled to −180°C without additional cryoprotectant. Native and far remote data were collected to 1.55 Å resolution at SSRL beamline 11-1 and MAD data (peak, inflection, and remote wavelengths) were collected at ALS beamline 5.0.2 (Table 1 ). All data were processed and scaled in HKL2000 (Otwinowski and Minor 1997) . The space group is orthorhombic P2 1 2 1 2 with unit cell dimensions a = 116.1 Å, b = 86.0 Å, and c = 80.2 Å, and two protein molecules per asymmetric unit (V m = 2.4 Å 3 /Da).
Structure determination and refinement
Positions of Se atoms (20 of 22 possible) were determined and refined in SOLVE and RESOLVE (Terwilliger and Berendzen 1996) . Phase extension and automated chain tracing using the native data were performed in ARP/WARP (Lamzin and Wilson 1993 ). Further refinement was performed in CNS (Brünger et al. 1998 ) with intervening rounds of manual model building using the program O (Jones et al. 1991) . Water molecules were added automatically using CNS (Brünger et al. 1998 ) and verified by manual inspection in O (Jones et al. 1991) . Additional analysis of the final model was performed with PROCHECK (Laskowski et al. 1993 ). The final model consists of 703 amino acid residues and 628 water molecules (Table 1) .
Domain analysis
The XOL-1 structure has a complex topology. Automated domain analysis programs TOPS (Westhead et al. 1999) 
Cloning of C. briggsae xol-1
The C. elegans XOL-1 amino acid sequence was compared with the unfinished genomic sequence of C. briggsae (The Sanger Institute, http://www.sanger.ac.uk; The Genome Sequencing Center, Washington University in St Louis, http://genome. wustl.edu) by TBLASTN with standard parameters. A short stretch of potential similarity was identified in C. briggsae cosmid CB030H15. Using the coding sequence predicted from the C. briggsae genome, gene-specific primers to the most highly conserved regions were used in conjunction with RACE and conventional PCR to isolate cDNA fragments corresponding to the transcribed xol-1 gene. When aligned with the C. elegans XOL-1 amino acid sequence by the clustal method (GONNET series), the ORF from the C. briggsae ortholog displays low sequence identity (22%). The C. briggsae dim-1 gene is found on cosmid CB027N19. Cosmids CB030H15 and CB027N19 are both found on contig cb25.fpc4044. In C. briggsae, xol-1 is ∼32 kb upstream of dim-1. In C. elegans, xol-1 is ∼10 kb upstream of dim-1.
ATPase assay
ATPase activity was measured using a maltose phosphorylaseglucose oxidase-horseradish peroxidase enzyme-coupled colorimetric assay (P i per Phosphatase Assay, Molecular Probes) according to the manufacturer's protocol. Briefly, XOL-1 (10 µg), MHC Class I H-2K b (10 µg; negative control) and Na + /K − -ATPase (5 milliunits; positive control) were incubated in the presence and absence of 1 mM ATP for various times up to 2 h at 37°C in 1× reaction buffer containing 100 µM Amplex red, 0.6 unit maltose phosphorylase, 0.3 unit glucose oxidase, and 0.6 unit horseradish peroxidase in a volume of 150 µL. Assays were performed and repeated in triplicate. Absorbance at 565 nm was measured in 96-well plates using a Molecular Devices SpectraMax 250 plate reader. Additional negative controls were ATP (1 mM) alone and buffer only.
Steady-state fluorescence spectroscopy
Data were acquired using a SLM-AMINCO 8100 spectrofluorimeter. The concentration of protein and ligand (TNP-ATP, Molecular Probes) were 20 µM in 20 mM tris-HCl (pH 8.0), 5 mM MgCl 2 at 25°C (volume = 150 µL). Emission was collected at 90°to the direction of excitation. To correct for fluctuation in the output from the 450 W xenon lamp, the experimental signal was divided by that of a quantum counter (3 g/L rhodamine G in ethylene glycol). To eliminate polarization artifacts, the excitation polarizer was set to the vertical position, and the emission polarizer was oriented 54.7°to the vertical (magic angle conditions). An excitation wavelength of 410 nm (8 nm = bandpass) and an emission maximum of 544 nm (8 nm = bandpass) for the bound ligand were determined experimentally. The sensitivity of the emission channel was set to 30% of maximum, resulting in a PMT voltage of 1050 V and a signal gain of 10 (voltage = 560 V and signal gain = 1 for reference channel). Emission spectra were collected from 490 to 600 nm with an integration time of 1 sec. Experiments were performed in triplicate, and spectra were corrected by subtracting the background fluorescence of the protein in the absence of ligand.
Coordinates Structure factors and atomic coordinates (accession no. 1MG7) have been deposited in the Protein Data Bank (http://www.rcsb.org/pdb).
